Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
Amphastar Pharmaceuticals (AMPH) - P/B ratio
P/B ratio as of April 2024 : 3.14
According to Amphastar Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 3.14.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Amphastar Pharmaceuticals - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.63 | 80.9% |
| 2022-12-31 | 2.56 | 2.41% |
| 2021-12-31 | 2.50 | 17.51% |
| 2020-12-31 | 2.13 | 1.29% |
| 2019-12-31 | 2.10 | -17.48% |
| 2018-12-31 | 2.55 | -3.91% |
| 2017-12-31 | 2.65 | 2.94% |
| 2016-12-31 | 2.57 | 18.3% |
| 2015-12-31 | 2.18 | 18.35% |
| 2014-12-31 | 1.84 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | 0.1329 | -95.77% | 🇺🇸 USA |
 SCYNEXIS SCYX | 0.6361 | -79.75% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | 4.60 | 46.51% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -0.2210 | -107.03% | 🇺🇸 USA |